Know Cancer

or
forgot password


N/A
18 Years
N/A
Not Enrolling
Both
Actinic Keratoses

Thank you

Trial Information


Inclusion Criteria:



- 18 years and older, 5 AK in face and scalp

Exclusion Criteria:

- immunosuppression

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment

Outcome Measure:

response rate

Outcome Time Frame:

3 months

Safety Issue:

No

Principal Investigator

Hans Christian Wulf, Professor

Investigator Role:

Principal Investigator

Investigator Affiliation:

Bispebjerg Hospital

Authority:

Denmark: Danish Medicines Agency

Study ID:

Multicenter Sun-PDT

NCT ID:

NCT00711178

Start Date:

June 2008

Completion Date:

January 2009

Related Keywords:

  • Actinic Keratoses
  • Keratosis
  • Keratosis, Actinic

Name

Location